{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:53:31Z","timestamp":1780437211833,"version":"3.54.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Previous studies have shown a protective effect of dexmedetomidine use in kidney transplantation. In contrast, it is not known whether intraoperative administration of dexmedetomidine can reduce early allograft dysfunction (EAD) incidence following liver transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To investigate the effect of dexmedetomidine use during surgery on EAD following orthotopic liver transplantation (OLT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study Design:<\/jats:title>\n            <jats:p>This is a single-center, double-blinded, placebo-controlled randomized clinical trial. Three hundred thirty adult patients undergoing OLT were enrolled from 14th January 2019 to 22nd May 2022. Patients received dexmedetomidine or normal saline during surgery. One year follow-ups were recorded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients were randomized to two groups receiving either dexmedetomidine or normal saline intraoperatively. For patients in the dexmedetomidine group, a loading dose (1\u00a0\u03bcg\/kg over 10\u00a0min) of dexmedetomidine was given after induction of anesthesia followed by a continuous infusion (0.5\u00a0\u03bcg\/kg \/h) until the end of surgery. For patients in the normal saline group, an equal volume loading dose of 0.9% saline was given after the induction of anesthesia followed by an equal volume continuous infusion until the end of surgery. The primary outcome was EAD. Secondary outcomes included primary graft nonfunction, acute kidney injury, and acute lung injury\/acute respiratory distress syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 330 patients included in the intention-to-treat analysis, 165 were in the dexmedetomidine group [mean (SD) age, 49 (10) years; 117 (70.9%) men], and 165 were in the normal saline group [mean SD age, 49 (9) years; 118 (74%) men]. 39 (24.4%) patients in the dexmedetomidine group and 31 (19.4%) in normal saline group developed EAD and the difference was statistically insignificant (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.28). Secondary outcomes including primary graft nonfunction and acute kidney injury was similar between the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intraoperative administration of dexmedetomidine did not reduce EAD rate after OLT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000001669","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:00:42Z","timestamp":1716228042000},"page":"5518-5526","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Dexmedetomidine use during orthotopic liver transplantation surgery on early allograft dysfunction: a randomized controlled trial"],"prefix":"10.1097","volume":"110","author":[{"given":"Liqun","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Masters","sequence":"additional","affiliation":[{"name":"Division of Anesthetics, Pain Medicine & Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Anesthetics, Pain Medicine & Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom"},{"name":"Perioperative and Systems Medicine Laboratory, Children\u2019s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai; Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9]]},"reference":[{"issue":"Suppl 1","key":"R1-20250824","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.jhep.2021.01.007","article-title":"Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation","volume":"75","author":"Burra","year":"2021","journal-title":"J Hepatol"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamasurg.2017.5040","article-title":"Evaluation of early allograft function using the liver graft assessment following transplantation risk score model","volume":"153","author":"Agopian","year":"2018","journal-title":"JAMA Surg"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2023.04.010","article-title":"A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease","volume":"79","author":"Guo","year":"2023","journal-title":"J Hepatol"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SLA.0000000000002726","article-title":"Arterial lactate concentration at the end of liver transplantation is an early predictor of primary graft dysfunction","volume":"270","author":"Golse","year":"2019","journal-title":"Ann Surg"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5604\/16652681.1184212","article-title":"Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements","volume":"15","author":"Lee","year":"2016","journal-title":"Ann Hepatol"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1097\/TXD.0000000000001182","article-title":"Early allograft dysfunction after liver transplantation with donation after circulatory death and brain death grafts: does the donor type matter?","volume":"7","author":"Mazilescu","year":"2021","journal-title":"Transplant Direct"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/jcm6070069","article-title":"An evaluation of ischaemic preconditioning as a method of reducing ischaemia reperfusion injury in liver surgery and transplantation","volume":"6","author":"Robertson","year":"2017","journal-title":"J Clin Med"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.tp.0000228235.55419.e8","article-title":"Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury","volume":"84","author":"Kanoria","year":"2007","journal-title":"Transplantation"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/SLA.0000000000003498","article-title":"Effect of remote ischemic preconditioning conducted in living liver donors on postoperative liver function in donors and recipients following liver transplantation: a randomized clinical trial","volume":"271","author":"Jung","year":"2020","journal-title":"Ann Surg"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/hep.32546","article-title":"Machine perfusion in liver transplantation","volume":"76","author":"Sousa Da Silva","year":"2022","journal-title":"Hepatology"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2022.01.024","article-title":"Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy","volume":"76","author":"Schlegel","year":"2022","journal-title":"J Hepatol"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/SLA.0000000000005110","article-title":"Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD)","volume":"274","author":"Czigany","year":"2021","journal-title":"Ann Surg"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"747911","DOI":"10.3389\/fphar.2021.747911","article-title":"The protective effect of dexmedetomidine against ischemia-reperfusion injury after hepatectomy: a meta-analysis of randomized controlled trials","volume":"12","author":"Huang","year":"2021","journal-title":"Front Pharmacol"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13054-017-1776-0","article-title":"Dexmedetomidine as a promising prevention strategy for cardiac surgery-associated acute kidney injury: a meta-analysis","volume":"21","author":"Shi","year":"2017","journal-title":"Crit Care"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13054-019-2690-4","article-title":"The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies","volume":"23","author":"Flanders","year":"2019","journal-title":"Crit Care"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bja.2019.12.036","article-title":"Effect of dexmedetomidine on acute kidney injury after aortic surgery: a single-centre, placebo-controlled, randomised controlled trial","volume":"124","author":"Soh","year":"2020","journal-title":"Br J Anaesth"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12967-021-03027-6","article-title":"Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia\/reperfusion injury via SIRT3-dependent PINK1\/HDAC3\/p53 pathway","volume":"19","author":"Zhang","year":"2021","journal-title":"J Transl Med"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"109631","DOI":"10.1016\/j.jclinane.2019.109631","article-title":"Dexmedetomidine exerts a protective effect on ischemia-reperfusion injury after hepatectomy: a prospective, randomized, controlled study","volume":"61","author":"Zhang","year":"2020","journal-title":"J Clin Anesth"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/cc7709","article-title":"Central sympatholytics prolong survival in experimental sepsis","volume":"13","author":"Hofer","year":"2009","journal-title":"Crit Care"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijsu.2012.12.003","article-title":"The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats","volume":"11","author":"Tufek","year":"2013","journal-title":"Int J Surg"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/ijms17070995","article-title":"Dexmedetomidine protects rat liver against ischemia-reperfusion injury partly by the alpha2A-adrenoceptor subtype and the mechanism is associated with the TLR4\/NF-kappaB pathway","volume":"17","author":"Wang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"508","DOI":"10.12659\/AOT.899340","article-title":"Effects of dexmedetomidine on postoperative cognitive dysfunction and serum levels of b-amyloid and neuronal microtubule-associated protein in orthotopic liver transplantation patients","volume":"21","author":"Xu","year":"2016","journal-title":"Ann Transplant"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s13063-020-04497-7","article-title":"Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation","volume":"21","author":"Ni","year":"2020","journal-title":"Trials"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"253517","DOI":"10.1155\/2012\/253517","article-title":"Milan criteria and UCSF criteria: a preliminary comparative study of liver transplantation outcomes in the United States","volume":"2012","author":"Patel","year":"2012","journal-title":"Int J Hepatol"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.22091","article-title":"Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors","volume":"16","author":"Olthoff","year":"2010","journal-title":"Liver Transpl"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/LVT.0000000000000173","article-title":"Early allograft dysfunction after living donor liver transplantation-current concepts and future directions","volume":"29","author":"Agrawal","year":"2023","journal-title":"Liver Transpl"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1159\/000522052","article-title":"Primary nonfunction and early allograft dysfunction after liver transplantation","volume":"40","author":"Masior","year":"2022","journal-title":"Dig Dis"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/lt.25633","article-title":"Impact of rifaximin therapy on ischemia\/reperfusion injury in liver transplantation: a propensity score-matched analysis","volume":"25","author":"Ito","year":"2019","journal-title":"Liver Transpl"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3748\/wjg.v18.i42.6141","article-title":"Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantation","volume":"18","author":"Zhu","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"6136105","DOI":"10.1155\/2020\/6136105","article-title":"Organ-protective effects and the underlying mechanism of dexmedetomidine","volume":"2020","author":"Bao","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"e2215217","DOI":"10.1001\/jamanetworkopen.2022.15217","article-title":"Effect of perioperative dexmedetomidine on delayed graft function following a donation-after-cardiac-death kidney transplant: a randomized clinical trial","volume":"5","author":"Shan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"4675817","DOI":"10.1155\/2016\/4675817","article-title":"Dexmedetomidine pretreatment attenuates kidney injury and oxidative stress during orthotopic autologous liver transplantation in rats","volume":"2016","author":"Yu","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/ph14080825","article-title":"Sedative and immunosuppressive effects of dexmedetomidine in transplantation","volume":"14","author":"Lee","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/ctr.12713","article-title":"Effect of dexmedetomidine on hepatic ischemia-reperfusion injury in the setting of adult living donor liver transplantation","volume":"30","author":"Fayed","year":"2016","journal-title":"Clin Transplant"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1213\/ANE.0000000000003761","article-title":"Pharmacokinetics of dexmedetomidine in infants and children after orthotopic liver transplantation","volume":"130","author":"Damian","year":"2020","journal-title":"Anesth Analg"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:19:12Z","timestamp":1756063152000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000001669","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"2024-04-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}